Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection

Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection

Hepatitis C virus (HCV) causes increased mortality and morbidity in kidney transplant patients. Interferon-based therapies are poorly tolerated and involve the risk of rejection. The new direct-acting antiviral drugs (DAAs) have revolutionized the treatment of HCV infection in transplant patients....

Full description

Bibliographic Details
Main Authors: Paolo Carta, Federica Curci, Leonardo Caroti, Larti Aida, Lorenzo Di Maria, Lino Cirami
Format: Article
Language:English
Published: Codon Publications 2020-05-01
Series:Journal of Renal and Hepatic Disorders
Subjects:
direct-acting antivirals
HCV infection
kidney transplantation
immunosuppression
Online Access:https://jrenhep.com/index.php/jrenhep/article/view/67

Similar Items

Similar Items